Pivotal Study of Fexinidazole for Human African Trypanosomiasis in Stage 2

NCT01685827 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

394

Enrollment

OTHER

Sponsor class

Conditions

Human African Trypanosomiasis (HAT)
Sleeping Sickness

Interventions

DRUG: Fexinidazole
DRUG: Nifurtimox
DRUG: Eflornithine

Sponsor

Drugs for Neglected Diseases